Atlas Trials

Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )

Clinical trial NCT04750707 · COMPLETED

Trial details

NCT number
NCT04750707
Sponsor
Global Health Uganda LTD
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell Anemia in Children
Start date
2021-03-09
Primary completion
2025-03-10
Enrollment
270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.